Ethyl 1-[2-(morpholin-4-yl)ethyl]-2-[4-(trifluoromethyl)phenyl]-1H-benzimidazole-5-carboxylate

Acta Crystallographica Section E

Structure Reports Online

Volume 67, Part 5 (May 2011)

organic compounds

hb5849 scheme

Acta Cryst. (2011). E67, o1215 [ doi:10.1107/S1600536811014619 ]

Ethyl 1-[2-(morpholin-4-yl)ethyl]-2-[4-(trifluoromethyl)phenyl]-1H-benzimidazole-5-carboxylate

Y. K. Yoon, M. A. Ali, T. S. Choon, M. Hemamalini and H.-K. Fun

Abstract: In the title compound, C₂₃H₂₄F₃N₃O₃, the morpholine ring adopts a chair conformation. The benzimidazole ring is approximately planar, with a maximum deviation of 0.028 (1) Å for one of the unsubstituted C atoms. The benzimidazole ring makes dihedral angles of 35.66 (4) and 75.45 (5)° with the attached phenyl and morpholine rings, respectively. In the crystal structure, adjacent molecules are linked via C-HF and C-HO hydrogen bonds to form a two-dimensional network.